(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 2. Identification of an enhancer to drive lacZ expression in the dorsal spinal cord. (A) Schematic representation of the genomic structure of Mbh1 and Mbh1/lacZ transgenes. The orange boxes indicate exons, and translation start site (ATG) is designated as nucleotide number 1. The blue and green boxes represent lacZ and the ß-globin promoter/lacZ construct (BGZA), respectively. The 3' fragment was reversed in Tg6. The number of transgenic (#TgM) and ß-gal+ (#expression) embryos are shown in the table; athe two embryos expressed lacZ at low levels in the midbrain. Lateral (B) and dorsal (C-E) views of representative ß-gal+ embryos harboring Tg2 (B,C), Tg4 (D) and Tg5 (E). Transverse sections of the embryos carrying Tg2 (F) and Tg4 (G). Arrowheads indicate ß-gal+ ventral funiculi. (H) Transverse section of the embryo carrying Tg4 was immunostained with antibodies against Math1 (red) and ß-gal (green). Scale bars: in B, 1 mm for B-E; in F, 100 µm for F,G; in H, 50 µm.